Therapeutic effect of autologous dendritic cell vaccine on patients with chronic hepatitis B: A clinical study

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 12

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

387

HTML

2561

Tables (1-2)

170

Sum=3118

Mar 28, 2005 (publication date) through Nov 3, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Mar 28, 2005; 11(12): 1806-1808
Published online Mar 28, 2005. doi: 10.3748/wjg.v11.i12.1806

Table 1 Clinical response of 19 patients treated by DC vaccine.

Patients	Cases	Difference in copies of HBV-DNA between pre- and post-treatment (mean±SD)	Rate of negative for HBeAg (%)	Rate of HBeAg/anti-HBe conversion (%)
Responder	11	3.074±2.397	91 (10/11)	45.5 (5/11)
Non-responder	8	-0.021±0.495	0 (0/8)	0 (0/8)
All patients	19¹	1.771±2.39^b	52.6 (10/19)	26.3 (5/19)

¹: total response rate = 57.9% (11/19);

^bP<0.01 (pair-matching t test: t = 3.13): Comparison analysis of the HBV-DNA copies of all patients between pre- and post-treatment.

Citation: Chen M, Li YG, Zhang DZ, Wang ZY, Zeng WQ, Shi XF, Guo Y, Guo SH, Ren H. Therapeutic effect of autologous dendritic cell vaccine on patients with chronic hepatitis B: A clinical study. World J Gastroenterol 2005; 11(12): 1806-1808
URL: https://www.wjgnet.com/1007-9327/full/v11/i12/1806.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i12.1806